Evaluating immune-related adverse events (irAEs) in a real-world cohort with lung cancer receiving immunotherapy

被引：0
|
作者：
Hu, Xiao [1 ]
Pan, Stacey [1 ]
Salei, Yana V. [2 ]
Lin, Jeffrey H. [2 ]
Parsons, Susan K. [1 ,3 ]
机构：
[1] Tufts Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA USA
[2] Tufts Med Ctr, Dept Med, Boston, MA USA
[3] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.67
引用
收藏
页码：E32 / E32
页数：1
相关论文
共 50 条
  • [1] Patterns and risk factors of immune-related adverse events in a real-world cohort with lung cancer receiving immunotherapy
    Hu, Xiao
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana
    Lin, Jeffrey
    Parsons, Susan K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Defining real-world criteria for immune-related adverse events (irAEs).
    Singh, Prabhsimranjot
    Brito, Amanda
    Abdulnour, Raja-Elie E.
    Grover, Shilpa
    Yenulevich, Eric
    Stuver, Sherri Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Real-world characterization of patients with cancer admitted with immune-related adverse events (irAEs).
    Eng, Lawson
    Chen, RuiQui
    Smith, Elliot Charles
    Chan, Sze Wah Samuel
    Hueniken, Katrina
    Brown, M. Catherine
    Majeed, Habeeb
    Ross, Kendra
    Gray, Diana
    Xu, Wei
    Hogg, David
    Sridhar, Srikala S.
    Sacher, Adrian G.
    Leighl, Natasha B.
    Krzyzanowska, Monika K.
    Liu, Geoffrey
    Butler, Marcus O.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [4] Immune-related adverse events (IrAEs) as a predictor of response to immunotherapy in patients with lung cancer
    Sanchez Becerra, M. V.
    Martinez-Cabanes, R.
    Gonzalez-Lopez, A.
    Zhan-Zhou, E.
    Sotelo, V.
    Esteban, M.
    Robles, T.
    Camara, J. C.
    Cardena, A.
    Hernando, S.
    Hurtado, A.
    Moreno, D.
    Olier, C.
    Mielgo Rubio, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S808 - S809
  • [5] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025,
  • [6] Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study
    Balko, Justin M.
    Yao, Lydia
    Zhang, Siwei
    Fahey, Catherine
    Haugh, Alexandra
    Davis, Andrea
    Mukherjee, Eric
    Hammer, Christian
    Phillips, Elizabeth J.
    Bejan, Cosmin A.
    Xu, Yaomin
    Johnson, Douglas Buckner
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): A real-world analysis
    Pretelli, G.
    Pavan, A.
    Dal Maso, A.
    Resi, M. V.
    Mulargiu, C.
    Ferro, A.
    Benetti, B.
    Lorenzi, M.
    Marinato, G. M.
    Frega, S.
    Pasello, G.
    Conte, P. F.
    Guarneri, V.
    Bonanno, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S51 - S51
  • [8] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [9] Focus on immune-related adverse events (irAEs) in immunotherapy of hepatobiliary malignancies
    Zhang, Lei
    Zhao, Haitao
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (03) : 348 - 349
  • [10] Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
    Zhou, Yixin
    Yu, Hui
    Chen, Chen
    Li, Anlin
    Zhang, Xuanye
    Qiu, Huijuan
    Du, Wei
    Fu, Sha
    Zhang, Li
    Hong, Shaodong
    EUROPEAN JOURNAL OF CANCER, 2024, 208
12345